Testosterone Treatment of Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline Educational Activity

This Endocrine Society Clinical Practice Guideline, Testosterone Treatment of Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline, emphasizes the importance of:

  • understanding basic principles of androgen deficiency screening, diagnosis, and treatment
  • informing patients regarding potential benefits and risks of testosterone treatment
  • monitoring treatment
  • sharing decision making with patients
  • informing patients of preventive care measures

Assess your knowledge with this 25 case based self-assessment. Each question includes a detailed answer discussion.

Target Audience

This continuing medical education activity should be of substantial interest to physicians seeking recertification in endocrinology and/or individuals seeking review and self-assessment in androgen deficiency syndromes in men.

Learning Objectives

Upon completion of this educational activity, participants will be able to:

  • Diagnose androgen deficiency syndromes in men  
  • Select appropriate therapeutic options for patients with diagnosed androgen deficiency  
  • Effectively manage prescribed therapies for these patients.
 

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Scientific researcher
Educator/Teacher
Pharmacist
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Medical Knowledge
Topic Area: 
Men’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Activity summary
Available credit: 
  • 5.00 ABIM MOC
  • 5.00 AMA PRA Category 1 Credits
  • 5.00 CME Certificate of Participation
Course opens: 
04/06/2018
Course expires: 
03/31/2020
Rating: 
0

Alvin M Matsumoto, MD
University of Washington School of Medicine
Treatment of Men with Hypogonadism Task Force Member

CONTRIUBTING FACULTY

Bradley D Anawalt, MD
University of Washington

Shehzad Basaria, MD
Boston University School of Medicine

STATEMENT OF INDEPENDENCE

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported relevant financial relationship(s):

Alvin M Matsumoto, MD is an advisory board member for Abbvie. A consultant for Abbvie and Up To Date, Aytu Bioscience. He is a grant recipient from Abbvie and GlaxoSmithKline.

Bradley D Anawalt, MD is an author for UpToDate and a consultant for the United States Anti-Doping Agency.

Shehzad Basaria, MD has no current conflicts related to this product. Previously, he had a grant from Solvay for an investigator-initiated Clinical Trial. He has previously given talks at academic symposia that were partly sponsored by AbbVie.

The following faculty members reported no relevant financial relationships:

The medical editor for this program, Abbie L. Young, MS, CGC, ELS(D), reported no relevant financial relationships.

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

DISCLAIMERS

The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.

USE OF PROFESSIONAL JUDGMENT:

The educational content in this self-assessment test relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

DRUGS AND DOSAGES:

When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY AND CONFIDENTIALITY STATEMENT

The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT

This activity is not supported by educational grant(s) or other funds from any commercial supporter.

Accreditation Statement

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this enduring material for a maximum of 5.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Activity Expiration Date

March 31, 2020 (date after which this enduring material is no longer certified for AMA PRA Category 1 Credits and ABIM Medical Knowledge MOC points)

For questions about content or obtaining CME credit or MOC points, please contact the Endocrine Society at http://education.endocrine.org/contact.

Available Credit

  • 5.00 ABIM MOC
  • 5.00 AMA PRA Category 1 Credits
  • 5.00 CME Certificate of Participation

Accreditation Period

Course opens: 
04/06/2018
Course expires: 
03/31/2020

Required Hardware/software

To complete this activity, participants must have access to a computer or mobile device with an Internet connection and use a major Web browser, such as Internet Explorer 10+, Firefox 32+, Safari 7+, or Google Chrome 37+. In addition, cookies must be enabled in the browser’s options.